Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1484 of 6351
-
New asthma pill shows promise in early trial
Symptom relief Recruiting nowThis study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LA…
Phase 2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New drug combo aims to protect kidneys in diabetes
Disease control Recruiting nowThis study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several …
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for dialysis patients: drug targets dangerous phosphorus levels
Disease control Recruiting nowA phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
Phase 3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a seizure drug lift bipolar depression?
Symptom relief Recruiting nowInitially, observational studies suggested a possible effect of Lacosamide on depressive and anxious symptoms in individuals with epilepsy, and later, an open-label study demonstrated the efficacy of lacosamide in improving depressive and manic symptoms in individuals with bipola…
Phase 3 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a diabetes drug help hearts heal better after a heart attack?
Disease control Recruiting nowAcute myocardial infarction (MI) remains one of the leading causes of cardiovascular morbidity and mortality worldwide. It most commonly occurs due to acute coronary artery occlusion following rupture or erosion of an atherosclerotic plaque and subsequent thrombus formation. Desp…
Sponsor: University of Athens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can headphones silence the stress of a noisy heart procedure?
Symptom relief CompletedBackground: Rotational atherectomy (RA) generates high-intensity drilling noise concentrated around 3000 Hz, creating a distinctive auditory stressor that may exacerbate perioperative anxiety and autonomic dysregulation in patients undergoing percutaneous coronary intervention. D…
Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New shot shows promise for severe eczema sufferers
Symptom relief OngoingThis trial was designed to evaluate the efficacy and safety of SHR-1819 in adult patients with moderate-to-severe atopic dermatitis.
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
A sharper MRI lens for injured infant nerves?
Diagnosis Recruiting nowThe objective of this prospective study is to contribute to improving the management of patients with obstetric brachial plexus palsy. The main objective is the characterization of the microstructure by diffusion MRI in patients with a history of unoperated obstetrical brachial …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo aims to shrink prostate tumors before surgery
Disease control Recruiting nowThe purpose of this study is to find out whether BMS986365 in combination with degarelix, given before standard surgical treatment (radical prostatectomy), is a safe and effective treatment that causes few or mild side effects for people who have localized high-risk prostate canc…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill takes aim at genetic weakness in tough blood cancers
Disease control Recruiting nowThe purpose of this study is to understand the safety, tolerability, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy of orally administered AZD3632 in participants with advanced haematologic malignancies with KMT2Ar, NPM1m, or other genotypes associ…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New program aims to tame Africa's blood pressure crisis
Disease control Recruiting nowThe ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous a…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can sound waves to the spleen alter blood clotting?
Knowledge-focused Recruiting nowThis is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New hope for kids with fabry: migalastat trial opens
Disease control Recruiting nowAn open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat treatment in pediatric subjects 2 to \< 12 years of age with Fabry disease and with amenable GLA variants.
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for cancer patients who stopped responding to immunotherapy?
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carcinoma and non-small cell lung carcinoma. The main question it aims to answer is: What is the maximum dose of ruxolitini…
Phase 1/2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of RMC-5127 as a monotherapy and in combination with either daraxonrasib or cetuximab in adults with KRAS G12V-mutant solid tumors.
Phase 1 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New device could help colon cancer patients avoid a stoma bag
Disease control By invitation onlyColorectal cancer is the third most common malignancy worldwide and the second most common in the US. It is the second leading cause of cancer death worldwide, with 1.8 million new cases and 862,000 deaths per year. The majority of patients receive surgical treatment. Colorectal …
Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain-Health app and coaching trial aims to prevent dementia in At-Risk seniors
Prevention Not yet recruitingThe goal of this clinical trial is to learn whether a hybrid multidomain lifestyle program can prevent cognitive decline and reduce dementia risk in community-dwelling adults in mid- to late life who are at increased risk of Alzheimer´s disease or related dementias but do not yet…
Sponsor: Medical University of Vienna • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New hope: Stomach-Stitching procedure aims to cut obesity risks in endometrial cancer survivors
Disease control Recruiting nowObesity increases the risk of endometrial cancer, with higher Body Mass Index (BMI) leading to a significant increase in both cancer risk and recurrence. Because of the excellent cancer-specific outcomes and preponderance of obesity-related complications, women with endometrial c…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can 3D heart scans outperform standard ultrasound in predicting risk?
Knowledge-focused Recruiting nowThis study will compare two ultrasound techniques, 2D and 3D speckle-tracking echocardiography, for measuring how well the heart muscle contracts in patients with heart failure and reduced pumping function. While 2D global longitudinal strain (GLS) is widely used and has proven v…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
AI therapy aims to curb suicide risk in older HIV patients
Symptom relief Recruiting nowOne in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address …
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC